| Literature DB >> 16217705 |
E Bertini1, M A Donati, P Broda, D Cassandrini, S Petrini, C Dionisi-Vici, L Ballerini, R Boldrini, A D'Amico, E Pasquini, C Minetti, F M Santorelli, C Bruno.
Abstract
Danon disease, an X-linked cardioskeletal myopathy caused by primary deficiency of lysosome-associated membrane protein-2 (LAMP-2), is clinically characterized by cardiomyopathy, myopathy, and variable mental retardation. The pathological hallmark of the disease is the absence of LAMP-2 immunohistochemical staining in muscle. The LAMP-2 gene mutations reported thus far are generally private mutations. We describe two cases of Danon disease with different clinical presentation, in whom we identified the same exon skipping mutation c.928G>A in the LAMP-2 gene. The first patient was affected by an early onset myopathy and hypertrophic cardiomyopathy (HCM) that partially improved with drug treatment. A first muscle biopsy at age 4 months showed markedly increased glycogen, and acid maltase deficiency was ruled out biochemically. A second muscle biopsy, performed at age 3(1/2) years, showed very mild abnormalities. The second child at age 15 years had mild, diffuse muscle weakness and wasting, moderate mental deficiency, and HCM. Two serial biopsies performed at age 8 and 15 years showed similar findings of multiple esterase-positive vacuoles in type I myofibers. In both patients the immunohistochemical study demonstrated the absence of LAMP-2 in skeletal muscle.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16217705 DOI: 10.1055/s-2005-872844
Source DB: PubMed Journal: Neuropediatrics ISSN: 0174-304X Impact factor: 1.947